Fuji Pharma Co., Ltd. (FRA:FUP)

Germany flag Germany · Delayed Price · Currency is EUR
9.05
+0.10 (1.12%)
Last updated: Oct 20, 2025, 8:03 AM CET
1.12%
Market Cap219.70M
Revenue (ttm)294.72M
Net Income (ttm)18.10M
Shares Outn/a
EPS (ttm)0.74
PE Ratio12.14
Forward PEn/a
Dividend0.27 (2.99%)
Ex-Dividend DateSep 29, 2025
Volumen/a
Average Volume8
Open9.05
Previous Close8.95
Day's Range9.05 - 9.05
52-Week Range7.25 - 10.30
Betan/a
RSI51.84
Earnings DateNov 11, 2025

About Fuji Pharma

Fuji Pharma Co., Ltd. engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally. The company offers injection agents, internal drugs, drugs for external use, and diagnostic products. It also provides medical care for women, in vitro diagnostics, acute medical care products, and curative medicines, as well as information regarding pharmaceuticals and health; and contract manufacturing services. Fuji Pharma Co., Ltd. was founded in 1959 and is headquartered in Tokyo, Japan. [Read more]

Industry Pharmaceutical Preparations
Founded 1959
Employees 1,658
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol FUP
Full Company Profile

Financial Performance

In 2024, Fuji Pharma's revenue was 46.14 billion, an increase of 12.84% compared to the previous year's 40.89 billion. Earnings were 6.15 billion, an increase of 78.92%.

Financial numbers in JPY Financial Statements

News

There is no news available yet.